These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 16431252

  • 1. A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy.
    Ponticelli C, Passerini P, Salvadori M, Manno C, Viola BF, Pasquali S, Mandolfo S, Messa P.
    Am J Kidney Dis; 2006 Feb; 47(2):233-40. PubMed ID: 16431252
    [Abstract] [Full Text] [Related]

  • 2. A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.
    Ponticelli C, Zucchelli P, Passerini P, Cagnoli L, Cesana B, Pozzi C, Pasquali S, Imbasciati E, Grassi C, Redaelli B.
    N Engl J Med; 1989 Jan 05; 320(1):8-13. PubMed ID: 2642605
    [Abstract] [Full Text] [Related]

  • 3. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group.
    Ponticelli C, Zucchelli P, Passerini P, Cesana B.
    N Engl J Med; 1992 Aug 27; 327(9):599-603. PubMed ID: 1640953
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy.
    Idasiak-Piechocka I, Oko A, Łochyńska-Bielecka K, Skrobańska B.
    Kidney Blood Press Res; 2009 Aug 27; 32(4):263-7. PubMed ID: 19776643
    [Abstract] [Full Text] [Related]

  • 5. A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy.
    Ponticelli C, Altieri P, Scolari F, Passerini P, Roccatello D, Cesana B, Melis P, Valzorio B, Sasdelli M, Pasquali S, Pozzi C, Piccoli G, Lupo A, Segagni S, Antonucci F, Dugo M, Minari M, Scalia A, Pedrini L, Pisano G, Grassi C, Farina M, Bellazzi R.
    J Am Soc Nephrol; 1998 Mar 27; 9(3):444-50. PubMed ID: 9513907
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Idiopathic membranous nephropathy in the elderly.
    Passerini P, Como G, Viganò E, Melis P, Pozzi C, Altieri P, Ponticelli C.
    Nephrol Dial Transplant; 1993 Mar 27; 8(12):1321-5. PubMed ID: 8159299
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of membranous lupus nephritis.
    Moroni G, Maccario M, Banfi G, Quaglini S, Ponticelli C.
    Am J Kidney Dis; 1998 Apr 27; 31(4):681-6. PubMed ID: 9531186
    [Abstract] [Full Text] [Related]

  • 10. Antioxidant treatment of therapy-resistant idiopathic membranous nephropathy with probucol: a pilot study.
    Haas M, Mayer G, Wirnsberger G, Holzer H, Ratschek M, Neyer U, Neuweiler J, Kramar R, Schneider B, Breiteneder-Geleff S, Regele HM, Hörl WH, Kerjaschki D.
    Wien Klin Wochenschr; 2002 Feb 28; 114(4):143-7. PubMed ID: 12060980
    [Abstract] [Full Text] [Related]

  • 11. Controlled trial of monthly alternated courses of steroid and chlorambucil for idiopathic membranous nephropathy.
    Ponticelli C, Zucchelli P, Imbasciati E, Cagnoli L, Pozzi C, Grassi C, Limido D, Pasquali S, Passerini P, Volpini T, Locatelli F.
    Proc Eur Dial Transplant Assoc; 1983 Feb 28; 19():717-23. PubMed ID: 6348763
    [Abstract] [Full Text] [Related]

  • 12. Comparison of immunosuppressive therapeutic regimens in patients with nephrotic syndrome due to idiopathic membranous nephropathy.
    Kosmadakis G, Filiopoulos V, Smirloglou D, Skarlas P, Georgoulias C, Michail S.
    Ren Fail; 2010 Jun 28; 32(5):566-71. PubMed ID: 20486839
    [Abstract] [Full Text] [Related]

  • 13. Treatment and long-term follow-up of patients with stage II to III idiopathic membranous nephropathy.
    Polenakovik MH, Grcevska L.
    Am J Kidney Dis; 1999 Nov 28; 34(5):911-7. PubMed ID: 10561149
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Remissions and relapses in idiopathic membranous nephropathy.
    Ponticelli C, Passerini P, Altieri P, Locatelli F, Pappalettera M.
    Nephrol Dial Transplant; 1992 Nov 28; 7 Suppl 1():85-90. PubMed ID: 1337188
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
    du Buf-Vereijken PW, Branten AJ, Wetzels JF, Membranous Nephropathy Study Group.
    Nephrol Dial Transplant; 2004 May 28; 19(5):1142-8. PubMed ID: 14993502
    [Abstract] [Full Text] [Related]

  • 20. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
    Goumenos DS, Ahuja M, Davlouros P, El Nahas AM, Brown CB.
    Clin Nephrol; 2006 May 28; 65(5):317-23. PubMed ID: 16724651
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.